| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/22/1998 | EP0536275B1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/22/1998 | EP0515460B1 Docosahexaenoic acid, methods for its production and compounds containing the same |
| 04/22/1998 | EP0429480B1 Natriuretic hormone |
| 04/22/1998 | CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity |
| 04/22/1998 | CN1179418A Novel cyloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/21/1998 | US5741910 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools |
| 04/21/1998 | US5741821 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
| 04/21/1998 | US5741810 Prostaglandins for ocular hypotension for treatment of glaucoma |
| 04/21/1998 | US5741809 Compounds and methods for the treatment of cardiovascular inflammatory and immune disorders |
| 04/21/1998 | US5741808 Protein kinase inhibitors for treatmen of neurological disorders |
| 04/21/1998 | US5741804 Substituted benzimazoles which inhibit platelet aggrecation |
| 04/21/1998 | US5741801 Ketone compounds with aromatic groups and amino groups |
| 04/21/1998 | US5741782 Mixture of bactericide and fungicide; decontaminating tissue for transplantation |
| 04/21/1998 | US5741781 Mercaptoalkanoyldipeptide compounds |
| 04/21/1998 | US5741779 Slowing clot formation in blood by administering bactericidal/permeability-increasing protein product |
| 04/21/1998 | US5741776 Method of administration of IGF-I |
| 04/21/1998 | US5741486 Safe vectors for gene therapy |
| 04/21/1998 | CA2143301C N-(hydroxyethyl)butanediamide derivatives as renin inhibitors |
| 04/21/1998 | CA2143300C Renin inhibiting n-(2-amino-2-oxoethyl)butanediamide derivatives |
| 04/21/1998 | CA2087004C Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
| 04/16/1998 | WO1998015632A1 A human protein tyrosine kinase |
| 04/16/1998 | WO1998015624A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | WO1998015575A1 Promoter for smooth muscle cell expression |
| 04/16/1998 | WO1998015574A1 Methods and compositions for generating angiostatin |
| 04/16/1998 | WO1998015542A1 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
| 04/16/1998 | WO1998015521A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 04/16/1998 | WO1998015294A1 Mononuclear phagocytes in therapeutic drug delivery |
| 04/16/1998 | WO1998015281A1 Induction of a cellular stress response with heavy metal salts |
| 04/16/1998 | WO1998015272A1 Method for inhibiting stress-activated protein kinases |
| 04/16/1998 | WO1998015267A1 Method for the treatment of neurological or neuropsychiatric disorders |
| 04/16/1998 | DE3891033C2 Method for re-endothelialising denuded vascular lining |
| 04/16/1998 | DE19642591A1 Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung New piperidine-ketocarboxylic acid derivatives, their preparation and application |
| 04/16/1998 | DE19642451A1 Aminothiophencarbonsäureamide Aminothiophencarbonsäureamide |
| 04/16/1998 | DE19642255A1 Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten Use of 1-benzyl-3- (substituted-heteroaryl) -kondensierten pyrazole derivatives |
| 04/16/1998 | CA2268417A1 Mononuclear phagocytes in therapeutic drug delivery |
| 04/16/1998 | CA2268247A1 Induction of a cellular stress response with heavy metal salts |
| 04/16/1998 | CA2268022A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | CA2267967A1 Method for inhibiting stress-activated protein kinases |
| 04/16/1998 | CA2267381A1 Method for the treatment of neurological or neuropsychiatric disorders |
| 04/16/1998 | CA2267129A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 04/16/1998 | CA2267067A1 Promoter for smooth muscle cell expression |
| 04/16/1998 | CA2266424A1 A human protein tyrosine kinase |
| 04/16/1998 | CA2265550A1 Methods and compositions for generating angiostatin |
| 04/15/1998 | EP0835939A2 Fusion proteins with parts of immunoglobulins, their production and use |
| 04/15/1998 | EP0835937A2 Human MYT-1 kinase clone |
| 04/15/1998 | EP0835936A2 Arginyl tRNA synthase |
| 04/15/1998 | EP0835264A1 Human g-protein receptor hcegh45 |
| 04/15/1998 | EP0835263A2 Somatostatin peptides |
| 04/15/1998 | EP0835253A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 04/15/1998 | EP0835244A1 Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors |
| 04/15/1998 | EP0835135A2 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 04/15/1998 | EP0835128A1 Use of il-11 to treat inflammation |
| 04/15/1998 | EP0835116A1 Compounds and pharmaceutical compositions containing them |
| 04/15/1998 | EP0835115A1 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists |
| 04/15/1998 | EP0714388B1 Vasoconstrictive substituted aryloxyalkyl diamines |
| 04/15/1998 | CN1178698A Naoxinkang preparation and its producing technology |
| 04/15/1998 | CN1178670A Non freeze-drying powder injection of heart disease curing medicine and preparing method |
| 04/15/1998 | CN1038032C £(Benzodioxan, benzofuran or benzopyran) alkylamino| alkyl substituted guanidines and its preparing method, use and intermediate |
| 04/14/1998 | US5739351 Neurokinin a antagonists |
| 04/14/1998 | US5739340 Indolizine derivatives with pharmaceutical activity |
| 04/14/1998 | US5739322 Process for preparing BIS-indolyl macrocycles |
| 04/14/1998 | US5739308 Forms a duplex with a target nucleic acid and then form triplex with duplex formed between oligonucleotide and target ncleic acid |
| 04/14/1998 | US5739300 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/14/1998 | US5739274 Comprising polypeptide linked to phospholipid; produces delayed increase in blood pressure, increase in extracellular calcium uptake by vascular smooth muscle |
| 04/14/1998 | US5739166 Alkylsulfonyl or aminosulfonyl substituted aromatic compounds as non-steroidal antiinflammatory agent |
| 04/14/1998 | US5739164 Block metabotropic glutamate receptors |
| 04/14/1998 | US5739159 Medicaments for the treatment of cardiac insufficiency |
| 04/14/1998 | US5739157 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase |
| 04/14/1998 | US5739152 Pharmaceutical emulsion |
| 04/14/1998 | US5739142 4-aminobenzoylguanidine derivatives |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | US5739135 Inhibitors of microsomal triglyceride transfer protein and method |
| 04/14/1998 | US5739133 Pyridazinedione compounds useful in treating neurological disorders |
| 04/14/1998 | US5739123 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 04/14/1998 | US5739115 Sulfated maltooligosaccharides with heparin-like properties |
| 04/14/1998 | US5739103 Mutants; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarthritic agents |
| 04/14/1998 | CA2138298C Pyridopyrimidinone antianginal agents |
| 04/14/1998 | CA2015473C Triphenylmethane derivatives |
| 04/09/1998 | WO1998014618A1 Compositions and methods for the identification and treatment of patients at risk for heart failure |
| 04/09/1998 | WO1998014209A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | WO1998014197A1 Method of inhibiting smooth muscle cell proliferation |
| 04/09/1998 | WO1998014192A1 Vitronectin receptor antagonists |
| 04/09/1998 | WO1998014177A1 Methods and compositions employing red yeast fermentation products |
| 04/09/1998 | DE19637518A1 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung PTX-sensitive G-proteins, their production and use |
| 04/09/1998 | CA2267694A1 Method of inhibiting smooth muscle cell proliferation |
| 04/09/1998 | CA2267421A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | CA2267340A1 Methods and compositions employing red yeast fermentation products |
| 04/09/1998 | CA2267138A1 Compositions and methods for the identification and treatment of patients at risk for heart failure |
| 04/08/1998 | EP0834565A2 A G-protein coupled receptor HUVCT36 |
| 04/08/1998 | EP0834563A2 Human 7-transmembrane receptor, member of the chemokine receptor family, named Strl-33 |
| 04/08/1998 | EP0834562A1 Polypetide exhibiting calpain inhibition activity and method for the preparation thereof |
| 04/08/1998 | EP0834510A2 Flavone derivative and medicine comprising the same |
| 04/08/1998 | EP0833911A1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
| 04/08/1998 | EP0833907A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 04/08/1998 | EP0833828A1 Rapamycin derivatives |
| 04/08/1998 | EP0833823A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands |
| 04/08/1998 | EP0833819A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides |
| 04/08/1998 | EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| 04/08/1998 | EP0833659A1 Therapeutic fragments of von willebrand factor |
| 04/08/1998 | EP0833650A1 P-selectin ligands and related molecules and methods |